Michael Amoroso
2020 - Abeona Therapeutics
In 2020, Michael Amoroso earned a total compensation of $1.5M as Former President and Chief Executive Officer at Abeona Therapeutics.
Compensation breakdown
| Bonus | $106,400 |
|---|---|
| Option Awards | $827,294 |
| Salary | $219,071 |
| Stock Awards | $338,728 |
| Other | $7,667 |
| Total | $1,499,160 |
Amoroso received $827.3K in option awards, accounting for 55% of the total pay in 2020.
Amoroso also received $106.4K in bonus, $219.1K in salary, $338.7K in stock awards and $7.7K in other compensation.
Rankings
In 2020, Michael Amoroso's compensation ranked 6,819th out of 13,090 executives tracked by ExecPay. In other words, Amoroso earned more than 47.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,819 out of 13,090 | 48th |
Division Manufacturing | 2,841 out of 5,621 | 50th |
Major group Chemicals And Allied Products | 1,150 out of 2,254 | 49th |
Industry group Drugs | 990 out of 1,954 | 49th |
Industry Pharmaceutical Preparations | 737 out of 1,459 | 50th |
Source: SEC filing on July 11, 2022.
Amoroso's colleagues
We found one more compensation record of an executive who worked with Michael Amoroso at Abeona Therapeutics in 2020.
2020
Edward Carr
Abeona Therapeutics
Chief Financial Officer
News
PRECISION BIOSCIENCES CEO Michael Amoroso's 2023 pay falls 53% to $2M
April 25, 2024
PRECISION BIOSCIENCES CEO Michael Amoroso's 2022 pay falls 27% to $4.4M
March 23, 2023
Abeona Therapeutics CEO Michael Amoroso's 2021 pay jumps 104% to $3.1M
July 11, 2022
PRECISION BIOSCIENCES CEO Michael Amoroso's 2021 pay jumps 299% to $6M
March 29, 2022